Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

5.7K
Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

149
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
149
Enzyme Inhibition01:30

Enzyme Inhibition

78.0K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.0K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activity-dependent lipid droplet biogenesis and turnover regulate synaptic integrity.

bioRxiv : the preprint server for biology·2026
Same author

Sequential Penta-Omic Extraction Method Using Single Biospecimens of Post-mortem Human Brain.

bioRxiv : the preprint server for biology·2026
Same author

No evidence for direct physical interaction of 5-HT <sub>2A</sub> -mGluR2 receptors <i>in vitro</i> or <i>in vivo</i>.

bioRxiv : the preprint server for biology·2026
Same author

FDEM-BEM simulation of hydraulic fracture propagation and control factors in conglomerate reservoirs.

Scientific reports·2026
Same author

Acquisition of resistance to RAS inhibition is associated with the upregulation of macropinocytosis through both PI3K-dependent and -independent signaling.

Cancer research communications·2026
Same author

Non-destructive detection of multiple fatty acids in fuzzy cottonseeds based on near-infrared spectroscopy and chemometrics.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

Related Experiment Video

Updated: Jun 11, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.5K

Potent and Selective SETDB1 Covalent Negative Allosteric Modulator Reduces Methyltransferase Activity in Cells.

Mélanie Uguen, Devan J Shell, Madhushika Silva

    Biorxiv : the Preprint Server for Biology
    |October 10, 2024
    PubMed
    Summary

    Researchers developed UNC10013, a potent covalent ligand targeting the SETDB1 triple Tudor domain (3TD). This selective molecule modulates SETDB1 activity in cells, offering a new tool for studying cancer and neurodegenerative diseases.

    More Related Videos

    Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
    08:11

    Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

    Published on: August 7, 2021

    4.1K
    A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1
    08:17

    A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1

    Published on: April 16, 2021

    2.3K

    Related Experiment Videos

    Last Updated: Jun 11, 2025

    Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
    06:07

    Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

    Published on: August 5, 2022

    2.5K
    Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
    08:11

    Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

    Published on: August 7, 2021

    4.1K
    A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1
    08:17

    A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1

    Published on: April 16, 2021

    2.3K

    Area of Science:

    • Biochemistry
    • Chemical Biology
    • Epigenetics

    Background:

    • SETDB1 (SET Domain Bifurcated 1) is a key epigenetic regulator implicated in cancer and neurodegenerative diseases.
    • The triple Tudor domain (3TD) of SETDB1 functions as a reader of lysine methylation marks, crucial for its biological functions.

    Purpose of the Study:

    • To identify and characterize small molecule ligands targeting the SETDB1 3TD.
    • To develop a potent and selective covalent inhibitor for studying SETDB1's role in disease.

    Main Methods:

    • High-throughput screening to identify initial ligands.
    • Structure-based drug design and chemical optimization.
    • Biochemical assays to determine ligand potency and selectivity.
    • Cell-based assays to assess target engagement and functional effects.

    Main Results:

    • Discovery of UNC6535, a dual TD2/TD3 binder.
    • Development of UNC10013, the first covalent 3TD ligand targeting Cys385.
    • UNC10013 exhibits high potency (k inact /K I = 1.0 x 10 6 M -1 s -1) and proteome-wide selectivity.
    • UNC10013 acts as a negative allosteric modulator of SETDB1-mediated Akt methylation in cells.

    Conclusions:

    • UNC10013 is a potent, selective, and cell-active covalent ligand for the SETDB1 3TD.
    • This compound demonstrates negative allosteric modulator properties.
    • UNC10013 serves as a valuable chemical probe for investigating SETDB1's biological roles in disease progression.